Cytomos
1 known investors
Cytomos develops label-free cell analysis technology that measures intrinsic cell properties to provide predictive insights for bioprocessing and cell line development teams. Its offering is aimed at biopharma manufacturing to support process optimization and reduce time-to-market.
Investors Β· 1
Frequently asked questions
- What does Cytomos do?
- Cytomos develops label-free cell analysis technology that measures intrinsic cell properties to provide predictive insights for bioprocessing and cell line development teams. Its offering is aimed at biopharma manufacturing to support process optimization and reduce time-to-market.
- Who are Cytomos's investors?
- Cytomos's investors include Archangels.